These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. More on data monitoring and large apparent treatment effects. Anderson JR Contemp Clin Trials; 2005 Jun; 26(3):416-7. PubMed ID: 15911475 [No Abstract] [Full Text] [Related]
4. FDA signals it's open to drug trials that shift midcourse. Mathews AW Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817 [No Abstract] [Full Text] [Related]
5. Standard versus adaptive monitoring procedures: A commentary. Fleming TR Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447 [TBL] [Abstract][Full Text] [Related]
6. Information-based monitoring of clinical trials. Tsiatis AA Stat Med; 2006 Oct; 25(19):3236-44; discussion 3320-5, 3326-47. PubMed ID: 16927248 [TBL] [Abstract][Full Text] [Related]
8. Management and interpretation of data obtained from clinical trials in pain management. Theodore BR; Gatchel RJ Pain Pract; 2008; 8(6):461-72. PubMed ID: 19000174 [TBL] [Abstract][Full Text] [Related]
9. Clinical trials with allergen products--statistical considerations. Volkers P Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):172-80; discussion 181. PubMed ID: 17393737 [No Abstract] [Full Text] [Related]
10. Stopping clinical trials early for benefit: impact on estimation. Freidlin B; Korn EL Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463 [TBL] [Abstract][Full Text] [Related]
11. Randomized trials in oncology stopped early for benefit. Wilcox RA; Djulbegovic B; Moffitt HL; Guyatt GH; Montori VM J Clin Oncol; 2008 Jan; 26(1):18-9. PubMed ID: 18165635 [No Abstract] [Full Text] [Related]
12. Choosing the right sample. Gill J Radiol Technol; 2010; 81(6):610-1. PubMed ID: 20606055 [No Abstract] [Full Text] [Related]
13. P less than .05: what does it really mean? Kain ZN; MacLaren J Pediatrics; 2007 Mar; 119(3):608-10. PubMed ID: 17332213 [No Abstract] [Full Text] [Related]
14. Data Safety Monitoring Board (DSMB). Welch KM Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():46-7. PubMed ID: 15512871 [No Abstract] [Full Text] [Related]
15. [Quality monitoring in multi-central large sample acupuncture clinical trials]. Zhao L; Li Y; Zhang FW; Guang H Zhongguo Zhen Jiu; 2008 Nov; 28(11):835-7. PubMed ID: 19055291 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the statistical power for multiple tests: a case study. Yeo A; Qu Y Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588 [TBL] [Abstract][Full Text] [Related]
17. A probiotics trial on trial: the problem of timely detection of adverse advents in therapeutic trials. Giard RW J Clin Epidemiol; 2010 Apr; 63(4):347-9. PubMed ID: 19762211 [No Abstract] [Full Text] [Related]
19. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board. Wittes J; Barrett-Connor E; Braunwald E; Chesney M; Cohen HJ; Demets D; Dunn L; Dwyer J; Heaney RP; Vogel V; Walters L; Yusuf S Clin Trials; 2007; 4(3):218-34. PubMed ID: 17715247 [TBL] [Abstract][Full Text] [Related]
20. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials. Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]